As earlier published that Demis Hassabis, the CEO of Google DeepMind won the Nobel Prize, but interestingly, he did not win ...

Morgan Stanley raised the firm’s price target on BeOne Medicines (ONC) to $330 from $313 and keeps an Overweight rating on the shares following the R&D day that highlighted the company’s pipeline ...

In a recent interview, Microsoft CEO Satya Nadella emphasised that AI's real test lies in fixing real-world issues, and not just demos.